TheEdgeResearch
Home / Stocks / CANSF

Atlas Energy Corp. (CANSF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.08 ▲ +0.00%
Market Cap
$28.2M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
4.74
52-Wk Range
0.046-0.152
CEO
Mark Alan Hodgson
Country
CA
Currency
USD

Atlas Energy Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Calgary, AB, CA. The stock last traded at $0.08, up 0.00% on the session, giving a market capitalisation of $28.2M. On trailing twelve-month figures it carries a trailing P/E of -2.10, a net margin of 3.0%. Its beta of 4.74 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-2.10
Price / Sales
2.93
Price / Book
0.03
EV / EBITDA
21.24
Gross margin
100.0%
Operating margin
-72.9%
Net margin
3.0%
Return on equity
Debt / equity
0.00
Current ratio
32.23
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
19
IPO date
2021-01-08
Headquarters
Calgary, AB, CA
About Atlas Energy Corp.

Atlas Energy Corp. is a biotechnology firm established in 2019 and headquartered in Calgary, Canada. The company specializes in the creation, manufacturing, and distribution of plant-based ingredients, primarily catering to the consumer care, food and beverage, and pharmaceutical industries throughout the United States. Atlas Energy Corp. maintains a strategic licensing and development partnership with Laurus Labs, focusing on the advancement and commercialization of active pharmaceutical ingredients and various other compounds. The company, previously known as Willow Biosciences Inc., officially adopted the name Atlas Energy Corp. in June 2025.

Comparable companies

Atlas Energy Corp. is most often compared with the following Healthcare names:

CBSTFCXXIFDXBRFELIXFITHUFLEEEFMDDVFMRMDSNNVFTCNAF
More research on CANSF
CANSF technical analysis CANSF TheEdge Score Compare against peers
Open full interactive analysis & DCF →